Day Two in DC: Can pharma police everything online?
If day two of FDA's hearings on internet promotion of drugs and the use of social media had a totem animal, it would be the ostrich. The birds, heads buried, adorned many a slide designed to hammer home the point that many companies are so fearful of violating adverse events reporting requirements that they go out of their way not to monitor the Internet for reports.
The e-mail address(es) that you supply to use this service will only be used to send the requested article.